Search Within

Human Oncology and Pathogenesis Program

Formats
  1. Journal Article (3034)
  2. Meeting Abstract (2566)
  3. Review (138)
  4. Editorial (107)
  5. Book Section (54)
  6. Research Letter (42)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (16)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. GSK Faculty (5787)
  2. Department of Medicine (4331)
  3. Department of Pathology and Laboratory Medicine (3081)
  4. Tow Center for Developmental Oncology (TCDO) (2648)
  5. Solid Tumor Oncology Division (2641)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (2590)

More Groups

People
  1. Marc Ladanyi (1335)
  2. Ross Levine (787)
  3. David Solit (782)
  4. Michael Berger (772)
  5. Nikolaus Schultz (491)
  6. Maria Arcila (428)

More People

Years
  1. 2025 (191)
  2. 2024 (381)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (650)
  2. Blood (517)
  3. Cancer Research (413)
  4. Modern Pathology (300)
  5. Clinical Cancer Research (270)
  6. Laboratory Investigation (265)

More Publications

Publishers
  1. American Association for Cancer Research (877)
  2. Nature Publishing Group (769)
  3. American Society of Clinical Oncology (718)
  4. American Society of Hematology (564)
  5. Elsevier Inc. (409)
  6. Nature Research (314)

More Publishers

Results (6007)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells
    Journal Article

    Turk, M. J.; Guevara-Patiño, J. A.; Rizzuto, G. A.; Engelhorn, M. E.; Houghton, A. N.
    Journal of Experimental Medicine (2004)

    Fulltext@MSK | Save
  • Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis
    Journal Article

    Chen, W.; Cooper, T. K.; Zahnow, C. A.; Overholtzer, M.; Zhao, Z.; Ladanyi, M.; Karp, J. E.; Gokgoz, N.; Wunder, J. S.; Andrulis, I. L.; more...
    Cancer Cell (2004)

    Fulltext@MSK | Save
  • E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma
    Journal Article

    Saito, T.; Oda, Y.; Kawaguchi, K. I.; Sugimachi, K.; Yamamoto, H.; Tateishi, N.; Tanaka, K.; Matsuda, S.; Iwamoto, Y.; Ladanyi, M.; more...
    Oncogene (2004)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor Iressa (ZD1839) is significantly more effective than continuous dosing for sensitizing tumors to taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M. M.; Hudis, C. A.; Kris, M. G.; Scher, H. I.; Rosen, N.; Sirotnak, F. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • ID deficiency cooperates with ansamycins to inhibit the growth of breast tumors that develop spontaneously in MMTV-neu transgenic mice
    Meeting Abstract

    Solit, D. B.; De Candia, P.; Rosen, N.; Benezra, R.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Response and resistance to gefitinib (ZD1839, Iressa) in HER overexpressing tumor cells is mediated through the PI3K/Akt pathway
    Meeting Abstract

    She, Q. B.; Solit, D.; Basso, A.; Rosen, N.; Moasser, M. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Phase I trial to evaluate J591 as a vascular targeting agent in patients with advanced solid tumors
    Meeting Abstract

    Morris, M. J.; Divgi, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Shaffer, D.; Halpern, J.; Delacruz, A.; Curley, T.; Nacca, A.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • The methylthioadenosine phosphorylase (MTAP) gene is homozygously co-deleted with CDKN2A in most mesotheliomas: Detection by fluorescent in situ hybridization (FISH) and by immunohistochemistry (IHC) using a novel MTAP monoclonal antibody
    Meeting Abstract

    Illei, P. B.; Leoni, L.; Huang, W.; Astrow, S.; Cheeks, A.; Rusch, V. W.; Ladanyi, M.
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Rapid MicroPET imaging of 17AAG induced HER2 protein downregulation using Ga-68-DOTA-F(ab ')(2) herceptin
    Meeting Abstract

    Smith-Jones, P. M.; Solit, D.; Afroze, F.; Akhurst, T.; Rosen, N.; Larson, S. M.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save